Bian Xiaolong, Hu Haopu, Tian Cong, Wang Chenlong, Lai Chin-Hui, Wang Mingrui, Ji Jiaxiang, Xu Kexin, Xu Tao, Hu Hao
Department of Urology, Peking University People's Hospital, Xicheng, Beijing, China.
Peking University Applied Lithotripsy Institute, Peking University People's Hospital Xicheng, Beijing, China.
Int J Surg. 2025 Jul 1;111(7):4746-4755. doi: 10.1097/JS9.0000000000002384. Epub 2025 Jun 4.
Ureteral stent placement is a common treatment for relieving hydronephrosis due to ureteral strictures. Recently, segmental metal ureteral stents (MUSs) have emerged as a promising option. However, the efficacy and complications of different segmental MUSs remain controversial.
To evaluate and compare the efficacy and safety of different segmental MUSs as the long-term maintenance therapy across different years for ureteral strictures caused by various etiologies.
A systematic search of databases, including PubMed, Web of Science, and Embase, was conducted to identify studies that employed segmental MUSs. The primary success was defined as the absence of complications necessitating further intervention following successful stent placement and continued patency. The weighted pooled primary success rates of different segmental MUSs were calculated using R over three duration intervals: less than 1, 1-2, and more than 2 years.
A total of 31 studies, comprising 1660 cases, were included in the meta-analysis. The weighted pooled primary success rates for segmental MUSs were 73% (95% CI [70%, 77%], I2 = 18%) for durations of less than 1 year, 66% (95% CI [56%, 75%], I2 = 90%) for 1-2 years, and 39% (95% CI [23%, 55%], I2 = 90%) for more than 2 years. The variation in stent types was identified as a significant source of heterogeneity. Notably, the Allium stent exhibited a primary success rate of 81% (95% CI [75%, 87%], I2 = 63%) for the 1-2-year period, and 65% (95% CI [54%, 76%], I2 = 0%) for durations exceeding 2 years, significantly outperforming both the Uventa (1-2 year: 51%; >2 year: 23%) and Memokath (1-2 year: 53%; >2 year: 23%) ( P < 0.001). Moreover, covered stents demonstrated significantly greater efficacy than uncovered stents for 1-2 years (75% vs. 53%; P = 0.01). Complications leading to stent failure primarily included obstruction, migration, encrustation, and urinary tract infection.
The safety and efficacy of various segmental MUSs as long-term maintenance therapy for ureteral strictures vary significantly. The Allium stent showing a marked advantage over other stents, making it a preferred choice for long-term management.
输尿管支架置入术是缓解输尿管狭窄所致肾积水的常用治疗方法。近年来,分段式金属输尿管支架(MUSs)已成为一种有前景的选择。然而,不同分段式MUSs的疗效和并发症仍存在争议。
评估和比较不同分段式MUSs作为各种病因所致输尿管狭窄不同年份长期维持治疗的疗效和安全性。
系统检索包括PubMed、Web of Science和Embase在内的数据库,以确定采用分段式MUSs的研究。主要成功定义为支架置入成功后无需要进一步干预的并发症且保持通畅。使用R计算不同分段式MUSs在三个时间段(少于1年、1 - 2年和超过2年)的加权合并主要成功率。
荟萃分析共纳入31项研究,1660例病例。分段式MUSs在少于1年的时间段加权合并主要成功率为73%(95%可信区间[70%,77%],I² = 18%),1 - 2年为66%(95%可信区间[56%,75%],I² = 90%),超过2年为39%(95%可信区间[23%,55%],I² = 90%)。支架类型的差异被确定为异质性的重要来源。值得注意的是,葱状支架在1 - 2年期间的主要成功率为81%(95%可信区间[75%,87%],I² = 63%),超过2年为65%(95%可信区间[54%,76%],I² = 0%),显著优于Uventa支架(1 - 2年:51%;>2年:23%)和Memokath支架(1 - 2年:53%;>2年:23%)(P < 0.001)。此外,覆膜支架在1 - 2年的疗效显著高于非覆膜支架(75%对53%;P = 0.01)。导致支架失败的并发症主要包括梗阻、移位、结壳和尿路感染。
各种分段式MUSs作为输尿管狭窄长期维持治疗的安全性和疗效差异显著。葱状支架比其他支架具有明显优势,使其成为长期管理的首选。